Market Talk: Active Stocks to Watch - PZOO, SNSS, TNSX, CTIC
September 11 2012 - 12:00PM
Marketwired
FinancialNewsMedia.com "stocks to watch" for today: Pazoo, Inc.
(OTCBB: PZOO), Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS),
Transax International Ltd. (PINKSHEETS: TNSX), Cell Therapeutics,
Inc. (NASDAQ: CTIC)
News Update issued for PZOO.OB: Pazoo Unveils
the "MAX" Line of Health, Wellness and Nutri-Ceutical Products.
PZOO also received news late last week it has secured DTC
Eligibility.
Headline News: Pazoo, Inc. (OTCBB: PZOO) is excited to present
for distribution the MAX Line of Health, Wellness and
Nutri-Ceutical Products. The initial product releases will be the
MAXPLUS Multivitamin Powered by CELLMAX and CELLMAX Stem cell
nutrition concentrate. To follow in the 4th quarter of this year
will be a water oxygenator for people and one for pets. By the end
of 2012 or early in the 1st quarter of 2013 an anti-aging product
will be added to the MAX Line as well as a MAX line product for
aches and pains. Trademark applications have been filed to protect
the branding of this new line allowing Pazoo to bring these
products to market.
See this news as the latest Video Press Release on Youtube.com -
http://youtu.be/Y0kG-zQbg7k
The Creator of these products has already generated an extremely
positive reaction and has testimonials from people with very
serious ailments as to the incredible beneficial results from using
these products. Not only are several of these products patented,
but there is ample inventory for immediate introduction to the
market.
Pazoo expects to quickly ramp up revenues with the introduction
of these products into the market initially through direct response
programs later this month. Distribution into and through brick and
mortar retail is expected in the second quarter of 2013. Pazoo
expects to have at least ten products in direct response and retail
distribution channels before the end of June 2013.
David M. Cunic, CEO of Pazoo, Inc., stated, "I have never been
more excited in my life to be involved with such a dynamic company
that is on the cutting edge of providing health and wellness
information, products and services to people and their pets. We
really are going to make a positive difference in the lives of so
many people and their pets -- just fantastic, really
fantastic!"
For more details and to read the entire press release issued by
PZOO that includes the full company disclosures please go to
http://www.financialnewsmedia.com/stock-investing-business-investing-news/featured-news.php?id=205
Don't miss out on future alerts of this
emerging company, sign up for our free News Alerts now at
http://www.financialnewsmedia.com.
Get an edge on the market with our Premium News
Alerts that are FREE for a limited time at
http://www.financialnewsmedia.com.
Follow us on Facebook:
http://www.facebook.com/financialnewsmedia and Twitter:
http://twitter.com/FNMgroup
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced
that it will implement a one-time 225-patient sample size increase
to its Phase 3 VALOR trial of vosaroxin in acute myeloid leukemia
(AML), bringing target enrollment to 675 patients.
Transax International Ltd. (PINKSHEETS: TNSX) provides
information network solutions for healthcare providers and health
insurance companies. The Company's products support the real-time
automation of patient eligibility verifications, authorizations,
claims processing, and payment functions that are currently
performed manually
Cell Therapeutics, Inc. (NASDAQ: CTIC), a company focused on
translating science into novel cancer therapies, today announced
the initiation of the commercial launch of Pixuvri in the European
Union with entry into Sweden, Denmark and Finland in September, to
be followed by Austria and Norway in early October 2012 and
Germany, United Kingdom and the Netherlands in November 2012.
If you're a company interested in having FN
Media Group assist you with creating a greater awareness for your
next news release utilizing our multi-media and leading edge
outreach solutions, contact us now at
info@financialnewsmedia.com
DISCLAIMER: FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM) which disseminates electronic
information through multiple online media channels. FNMG's intended
purposes are to deliver market updates and news alerts issued from
private and publicly trading companies as well as providing
coverage and increased awareness for companies that issue press to
the public via online newswires. FNMG and its affiliated companies
are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no
investment licenses and may NOT sell, offer to sell or offer to buy
any security. FNMG's market updates, news alerts and corporate
profiles are NOT a solicitation or recommendation to buy, sell or
hold securities. An offer to buy or sell can be made only with
accompanying disclosure documents from the company offering or
selling securities and only in the states and provinces for which
they are approved. The material in this release is
intended to be strictly informational and is NEVER to be construed
or interpreted as research material. All readers are strongly
urged to perform research and due diligence on their own and
consult a licensed financial professional before considering any
level of investing in stocks. The companies that are discussed in
this release may or may not have approved the statements made in
this release. Information in this release is derived from a variety
of sources that may or may not include the referenced company's
publicly disseminated information. The accuracy or completeness of
the information is not warranted and is only as reliable as the
sources from which it was obtained. While this information is
believed to be reliable, such reliability cannot be guaranteed.
FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material
fact in this release. This release may contain technical
inaccuracies or typographical errors. It is strongly recommended
that any purchase or sale decision be discussed with a financial
adviser, or a broker-dealer, or a member of any financial
regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high
degree of risk. FNMG is not liable for any investment decisions by
its readers or subscribers. Investors are cautioned that they may
lose all or a portion of their investment when investing in
stocks.
This release is not without bias, and is considered a conflict
of interest if compensation has been received by FNMG for its
dissemination. To comply with Section 17(b) of the Securities Act
of 1933, FNMG shall always disclose any compensation it has
received, or expects to receive in the future, for the
dissemination of the information found herein on behalf of one or
more of the companies mentioned in this release. For disseminating
this release, FNMG was compensated seven hundred fifty dollars for
this news release on behalf of Pazoo, Inc. (OTCBB: PZOO).
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS
RELEASE.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may", "future", "plan" or "planned", "will" or "should",
"expected", "anticipates", "draft", "eventually" or "projected".
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and FNMG undertakes no
obligation to update such statements.
Contact Information: Contact email: Email Contact URL:
http://www.financialnewsmedia.com Company:
FinancialNewsMedia.com
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024